<DOC>
	<DOCNO>NCT00424567</DOCNO>
	<brief_summary>The purpose multi-center study obtain clinical data substantiate Aastrom TRC autologous bone marrow cell regenerate bone patient establish ( appendicular skeletal ) non union fracture , use one commonly employ commercially available allograft chip matrix .</brief_summary>
	<brief_title>Feasibility Study Aastrom Tissue Repair Cells Treat Non-Union Fractures .</brief_title>
	<detailed_description>The current standard care regeneration atrophic long bone fracture non-union autologous bone marrow chisel patient 's iliac crest open surgery general anesthesia . This method harvest bone marrow associate substantial morbidity long-term pain , possibility deep-seated infection site bone harvest indirect consequence extend time surgery , substantial expense potential blood transfusion . The procedure also associate bone graft failure rate least 20 % . Due substantial morbidity result aggressive open surgical procedure , alternative seek . Current alternative autologous bone include commercially available synthetic , xenograft allograft matrix , either use alone combine bone autograft . Cell-free substitute , matrix combine platelet rich plasma recombinant bone morphogenic protein osteoinductivity , also use . These alternative , although less morbid full bone harvest , yet stringently determine equivalent . Therefore , continue search additional improve alternative . Aastrom Biosciences , Inc. develop unique process grow human bone marrow , include early stem cell population , small sample percutaneously aspirate bone marrow . The process carry AastromReplicell Cell Production System ( ARS ) . The study perform obtain clinical data substantiate Aastrom TRC autologous bone marrow cell regenerate bone patient establish non union fracture , use one commonly employ commercially available allograft chip matrix . The bone marrow cell obtain brief , percutaneous , small volume aspiration ( approximately 30 - 50 ml ) posterior iliac crest obtain local conscious sedation . Percutaneous marrow aspiration substantially less morbid time consume current open surgical process bone autograft harvest . The study treat 36 patient ( 11 first group 25 second group ) . Patients treat use standard surgical procedure treatment non union fracture ( include commonly use hardware need stabilize fracture ) . The processed cell mixed commercially available bone matrix surgery place area fracture . Patients monitor 12 month follow surgery .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Pseudarthrosis</mesh_term>
	<mesh_term>Fractures , Ununited</mesh_term>
	<criteria>Type IIIA IIIB fracture Fracture gap &lt; 6 cm . Distance &gt; 4 cm joint No clinical sign infection wound site fracture site . Adult patient &gt; 18 year age . Male patient female patient pregnant lactate . Patients must normal organ marrow function define : 1 . Leukocytes &gt; =3000/microliters 2 . Absolute neutrophil count &gt; =1500/microliters 3 . Platelets &gt; =100,000/microliters 4 . AST ( SGOT ) /ALT ( SGPT ) &lt; 2.5 x institutional limit 5 . Creatinine within normal limit creatinine clearance calculate ) &gt; =60 mL/min/1.73 square miter creatinine institutional normal . Patients able give inform consent Other long bone fracture , e.g clavicle Patients unable discontinue ethanol use surgery include require pharmacologic adjuvant assistance . 1 . Although exclusion criterion , attend physician shall discuss patient advantage discontinue smoking cigarette and/or cigar term study include discontinue use pharmacologic adjuvant assistance nicotine suppression . 2 . The use discontinuance ethanol and/or cigarettes/cigars note patient 's case report form . Patients require corticosteroid antiinflammatory therapy surgery . Patients genetic metabolic bone disease hypophosphatasia , metabolic bone disorder primary secondary hyperparathyroidism cause chronic renal insufficiency disorder . Patients unable tolerate general anesthesia define ASA criterion 0 1 . Patients systemic antibiotic suspect wound fracture site infection . Patients diabetes . Glasgow score &lt; 13 . Injury severity score &gt; 25 . Allergy protein product derive mammalian source ( horse , bovine porcine ) require exvivo cell production process .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Fracture</keyword>
	<keyword>non union fracture</keyword>
	<keyword>ununited fracture</keyword>
	<keyword>pseudarthrosis</keyword>
</DOC>